. The gene encoding COX-2 (Ptgs2 in the mouse) is about 8 kb (Xie et al., 1991; Kujubu et al., 1991; O'Banion et al., 1991) and produces a message of about 4.1 kb (Xie et al., 1991; Kujubu et al., 1991; O'Banion et al., 1991; Kujubu and Herschman, 1992; DuBois et al., 1994b (Smith et al., 1993 (Smith et al., , 1994 Samet et al., 1995; Murakami et al., 1995) . COX-1 is thought to carry out primarily"housekeeping" functions such as cytoprotection of the gastric mucosa, regulation of renal blood flow, and platelet aggregation (Dewitt and Smith, 1988, 1990; Merlie et al., 1988; Funk et al., 1991) . In contrast, COX-2 message and protein are normally undetectable in most tissues; however, COX-2 expression in certain cell types can be rapidly induced by proinflammatory or mitogenic agents, including cytokines, endotoxins, tumor promoters, and mitogens (Xie et al., 1991; O'Banion et al., 1992; Hla and Neilson, 1992; Fletcher et al., 1992; DuBois et al., 1994a; Smith et al., 1994) .
Because of this rapid induction, the gene encoding COX-2 has been termed an immediate-early response or primary response gene (Simmons et al., 1989; Maier et al., 1990; Fletcher et al., 1992; Ryseck et al., 1992) . COX-2 message and protein have been shown to be up-regulated in human colon cancers (Eberhart et al., 1994; Kargman et al., 1995) and in mouse skin papillomas and carcinomas (Muller-Decker et al., 1995) . The COX isoforms are the primary target enzymes for NSAIDs, which act by inhibiting the activity of the enzymes (Vane, 1971; Smith and Willis, 1971; Smith et al., 1990; Xie et al., 1992; Seibert et al., 1994; Masferrer et al., 1994; Mitchell et al., 1994; Seibert and Masferrer, 1994) . Aspirin, the most common and best-studied NSAID, was originally shown to inhibit prostaglandin synthesis by Vane (1971 and Botting, 1992) and in reducing the incidence of colon cancer (Thun et al., 1991 (Thun et al., , 1993 Marnett, 1992 (Clive and Stoff, 1984; Black, 1986; Brooks and Day, 1991; Price and Fletcher, 1990; Simon, 1994) . Since the discovery of COX-2, the identification of drugs that selectively inhibit this isoform has become the focus of NSAID development (Xie et al., 1992; Meade et al., 1993; Seibert and Masferrer, 1994; Mitchell et al., 1994; Masferrer et al., 1994 et al., 1994; Crofford et al., 1994; Vane et al., 1994; Mitchell et al., 1994; Seibert et al., 1994; Vane, 1994; Simmons et al., 1991) (Xie et al., 1992; Seibert et al., 1994; Masferrer et al., 1994; Mitchell et al., 1994; Seibert and Masferrer, 1994) (Futaki et al., 1993; Rainsford, 1993; Beck et al., 1990) . Figure 1A ) were subcloned into Bluescript. A 4.3 kb Notl-Xhol fragment of the Xbal subclone was inserted into the pPNT vector (Tybulewicz et al., 1991) 5'to the Neo gene, and a 2.3 kb BamHl fragment from the Clal subclone was inserted 3' to the Neo gene to produce the targeting construct (Figure 1 B) .
Cell Culture and Targeting E14TG2a ES cells were cultured by conventional methods on feeder cells. The targeting vector was linearized with Notl and electroporated at 5 nM into about lOa trypsinized ES cells using a 1 s pulse at 300 V and 200 uF. Positive/negative selection was performed with G418 and ganciclovir (Mansour et al., 1988) with ganciclovir providing about a 1 O-fold enrichmentoverG418 alone. Ganciclovir-and G41 &resistant colonies were Isolated 8-9 days after electroporation and transferred individually to 24-well plates previously seeded with feeder cells, The cells were trypsinized 2 days later and reseeded into 6-well plates. After 2 days the cells were trypsinized, and about half were frozen at -80°C.
DNA isolated from the remaining half was used for PCR and genomic Southern blot analysis.
PCR and Southern
Blot Analysis PCR was the initial screen for identifying targeted ES cells and mice carrying the disrupted COX-7 gene (Kim and Smithies, 1988) . A primer specific for the Neo gene and a second primer specific for a genomic sequence 3'to sequences in the targeting construct ( Figure 1C) were blocked in 5% nonfat milk-Tris-buffered saline with 0.1% Tween 20 (TEST) before incubating with a rabbit antibody to murine COX-1 provided by Dr. D. Dewitt (Morita et al., 1995) or to COX-2 (Cayman Chemical).
Blots were incubated with anti-rabbit IgG horseradish peroxidase-linked secondary antibody (Boehringer Mannheim) in TBST and 1% nonfat milk. Chemiluminescent detection was performed using reagents from Amersham, and bands werevisualized after exposure to Hyperfilm-ECL (Amersham).
Indomethacin-Induced Stomach Ulceration lndomethacin wassuspended in 1% methyl cellulose at theconcentration of 1 or 2 mg/ml and given at the stated doses by gavage. All animals were fasted 16-18 hr prior to Savage. Animals were euthanized using CO, 6 hr after treatment, and their stomaches were removed and opened along the lesser curvature.
Stomach lesions were scored as described by Ghanayem et al. (1987) . The number of lesions were counted, an enlarged image of the formalin-fixed glandular stomach and of each individual lesion was traced, and the area of each lesion was determined using a computer-assisted image analysis system. The total area of the stomach was traced and measured.
The area of all lesions in each stomach was calculated and divided by the area of the glandular stomach to derive the percent of area with lesions. All samples were scored blind. No ulceration was shown by eight wild-type mice that received vehicle alone.
Mouse Ear Inflammation
Assay AA (2 mg per 10 ul) or TPA (1 ug per 10 ul) in acetone was applied to the inside of the left ear and 10 ~1 of acetone was applied to the right ear as described by Opas et al. (1985) . Ear swelling was determined after 2 hr for AA or 6 hr for TPA by the method of Gad et al. (1986) .
Macrophage
Isolation and PGEz Analysis Peritoneal macrophages were isolated and LPS stimulated by modification of the procedure of Watanabe et al. (1994) . Thioglycolateelicited macrophages were isolated by peritoneal lavage with 5 ml of cold RPM1 1840 medium. Macrophages were seeded at 1 x lo7 to 2.5 x 10' cells per 60 mm dish, depending on yield, and allowed to attach for 2 hr in a humidified incubator with 5% CO* in air. The plates were then washed with Hanks balanced salt solution to remove nonadhering ceils, and medium containing 1% serum with or without LPS (10 pglml) was then added. Attached cell numbers were determined by counting with an eyepiece micrometer.
After a 6 hr incubation, the medium was removed and replaced for30 min with medium containing 10 KM AA. Subsequent analysis for PGE? in the medium was by a competitive radioimmunoassay (Amersham).
Platelet Aggregation Platelet aggregation was carried out as described by Paigen et al. (1987) using AA to induce aggregation.
For each assay, blood was pooled from two mice (about 1 ml in total volume) and centrifuged to prepare platelet-rich and then platelet-poor plasma. The assay was conducted with 300 ~1 of plasma at 3 x lOa platelets per milliliter, Aggregation was induced by adding 15 frl of Na-AA (22 mg/ml in NazC03 buffer). Turbidity was measured with a Lumi-Aggregometer.
